Study flags knowledge gaps for shingles vaccine Research suggests that misconceptions remain about the shingles vaccine in use for the Government vaccination program for people over 70.
‘Breakthrough moment’: Monkeypox vaccine secured The Federal Government has procured 450,000 doses of the MPX vaccine, with the first shipments due to arrive shortly.
ATAGI approves Moderna vaccine for at-risk young children Parents are advised not to contact vaccine providers until bookings open, following decision to approve vaccination for the youngest cohort.
COVID vaccine safety data for children ‘extremely reassuring’ A new study tracking nearly 400,000 children aged 5–15 post-vaccination found adverse events were generally short-term and mild.
TGA green lights Nuvaxovid for 12–17-year-olds But while provisional approval has been granted, inclusion in the national program for this age group is yet to be confirmed.
Slight rise in adverse reactions for joint COVID and flu jabs A peer-reviewed article looking at the co-administration of COVID booster and flu vaccines in the US reports that most reactions tend to be mild.
Supply issues flagged as TGA provisionally approves Moderna for under-fives The Federal Health Minister has urged parents to delay booking COVID vaccine appointments for their very young children.
Awards will support risk-benefit analysis of COVID vaccination in kids A newly funded project will evaluate how risk communication for vaccines can be improved to boost vaccine uptake among children.
No plans for fourth COVID-19 vaccine dose for GPs The Department of Health has indicated that healthcare workers are more at risk of getting COVID-19 in the community than at work.
Australia records fifth Japanese encephalitis death The latest confirmed death has prompted health authorities to remind GPs of their role in vaccination uptake.